药物对比
Saxagliptin vs Repaglinide
Saxagliptin（DPP-4抑制剂）vs Repaglinide（氯茴苯酸类）治疗2型糖尿病。比较胰岛素释放、低血糖风险、餐时给药、体重和安全性。
此页面暂无可用的对比维度。
临床背景
This comparison arises when selecting an oral add-on agent for type 2 diabetes between a DPP-4 inhibitor and a meglitinide insulin secretagogue.
结论
Both lower blood sugar in type 2 diabetes but differ in class effects, so the better choice depends on hypoglycemia risk, meal patterns, and patient comorbidities.
全部药物对比